Abstract
The early clinical efforts at xenografting described by Reemtsma in Chap. 1 [1-4] and several additional efforts reported by Hitchcock [5], Starzl [6,7] and Hardy [8,9] were prompted by the shortage of human organs for transplantation at a time when there were few alternatives for treating end-stage organ failure. While none of these efforts achieved 1-year graft or patient survival, they did come close in several cases. Thus they demonstrated the potential for successful xenogeneic transplantation. Shortly after these first efforts, the concept of “brain death” became widely accepted, greatly increasing the supply of human organs for clinical transplantation and removing the principal justification for the use of animal organs. Thus only a few sporadic attempts at clinical xenogeneic transplantation were attempted over the next 25 years. However, one of the apparent consequences of this early chnical effort was to spark scientific interest in xenogeneic transplantation. Figure 3.1 shows the increased number of scientific publications involving xenografting which followed Reemtsma’s clinical effort. That interest lasted almost a decade before the frustrations of finding solutions to the problems and the lack of need for animal donors led to a dechne in the research effort.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Reemtsma, K. Renal heterotransplantation from nonhuman primates to man. Ann. N.Y. Acad. Sci. ;162, 412;1969.
Reemtsma, K.; McCracken, B. H.; Schlegel, J. V.; Pearl, M. Heterotransplantation of the kidney: two clinical experiences. Science 1964; 143:700.
Reemtsma, K.; McCracken, B. H.; Schlegel, J. U.; Pearl, M. A.; Pearce, C. W.; Dewitt, C. W.; Smith, P. E.; Hewitt, R. L.; Flinner, R. L.; Creech, O. Jr. Renal heterotransplantation in man. Ann Surg.; 1964; 160:384.
Reemtsma, K.; McCracken, B. H.; Schlegel, J. V.; Pearl, M. A.; Dewitt, C. W.; Creech, O. Jr. Reversal of early graft rejection after renal heterotransplantation in man. J.A.M.A.; 1964; 187:691.
Hitchcock, C. R.; Kiser, J. C.; Telander, R. L.; Seljeskob, E. L. Baboon renal grafts. J.A.M.A.; 1964; 189:934.
Starzl, T. E. Experiences in Renal Transplantation. Philadelphia: W. B. Saunders; 1964.
Starzl, T. E.; Marchioro, T. L.; Peters, G. N.; Kirkpatrick, C. H.; Wilson, W. E. C.; Porter, K. E.; Rifkind, D.; Ogden, D. A.; Hitchcock, C. R.; Waddell, W. R. Renal heterotransplantation from baboon to man: experience with six cases. Transplantation; 1964; 2:752.
Hardy, J. D.; Chavez, C. M.; Kurrus, F. D.; Neely, W. A.; Eraslan, S.; Turner, M. D.; Fabian, L. W.; Labecki, T. D. Heart transplantation in man: Developmental studies and report of a case. J.A.M.A.; 1964; 188:1132.
Hardy, J. D.; Chavez, C. M. The first heart transplant in man. Am. J. Cardiol; 1968; 22: 111.
Kissmeyer-Nielsen, F.; Olsen, S.; Petersen, V. P.; Fjeldborg, O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet; 1966;2:662.
Terasaki, P. L; Marchioro, T. H.; Starzl, T. E. Sero-typing of human lymphocyte antigens: preliminary trials on long-term kidney homograft survivors. In: Amos, D. B., (ed.) Workshop on Histocompatibility testing. Washington, D. C.: National Research Council; 1964:83.
Perper, R. J.; Najarian, J. S. Experimental renal heterotransplantation: II. Closely related species. Transplantation; 1966; 4:700.
Perper, R. J.; Najarian, J. S. Experimental renal heterotransplantation: L In widely divergent species. Transplantation; 1966; 4:377.
Calne, R. Y. Organ transplantation between widely disparate species. Transplant Proc.; 1970; 2:550.
Baldamus, C. A.; McKenzie, I. F. C.; Winn, H. J.; Russell, P. S. Acute destruction by humoral antibody of rat skin grafted to mice. J. Immunol; 1973; 110:1532.
Winn, H. J.; Baldamus, C. A.; Jooste, S. V.; Russell, P. S. Acute destruction by humoral antibody of rat skin grafted to mice: The role of complement and polymorphonuclear leukocytes. J. Exp. Med.; 1973; 137:893.
Rosenberg, J. C.; Broersma, R. J.; Bullemer, G.; Mammen, E. F.; Lenaghan, R.; Rosenberg, B. F. Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation; 1969; 8:152.
Rosenberg, J. C.; Hawkins, E.; Rector, F. Mechanisms of immunological injury during antibody-mediated hyperacute rejection of renal heterografts. Transplantation; 1971; 11:151.
Rosenberg, J. C.; Hawkins, E.; Mammen, E.; Palutke, M.; Riddle, J.; Rosenberg, B. F. Hyperacute rejection of heterografts: Studies of pig to dog renal transplants. In von Kaulla, K.; Thomas, C. C.; (ed.) Coagulation Problems in Transplanted Organs; 1971.
Shons, A. R.; Bier, M.; Jetzer, T.; Najarian, J. S. Techniques of in vivo plasma modification for the treatment of hyperacute rejection. Surgery; 1973; 73:28.
Shons, A. R.; Jetzer, J.; Moberg, A. W.; Najarian, J. S. Prolongation of heterograft survival by electrophorectic extraction of preformed antibody. Surg. Forum 1970; 21:263.
Shons, A. R.; Najarian, J. S. Xenograft rejection mechanisms in man. Trans. Am. Soc. Artif. Intern. Organs: 1974; 20: 562.
Shons, A. R.; Najarian, J. S. Modification of xenograft rejection by aspirin, dextran, and cinanserin: The importance of platelets in hyperacute rejection. Transplant Proc.: 1974; 6:435.
Moberg A. W.; Shons, A. R.; Gewürz, H.; Mozes, M.; Najarian, J. S. Prolongation of renal xenografts by the simultaneous sequestration of preformed antibody, inhibition of complement, coagulation, and antibody synthesis. Transplant Proc.: 1971; 3:538.
Hawkins, E.; Mammen, E.; Rosenberg, J. C. Effects of heparin and steroids on hypera- cutely rejected renal xenografts. J. Surg. Res.: 1971; 11:492.
Bier, M.; Beavers, C. D.; Merriman, W. G.; Merkel, F. K.; Eiseman, B.; Starzl, T. E. Selective plasmapharesis in dogs for delay of heterograft response. Trans. Am. Soc. Artif. Intern. Organs; 1970; 16:325.
Kux, M.; Boehmig, H. J.; Amemiya, H.; Torisu, M.; Yokoyama, T.; Launois, B.; Popovtzer, M.; Wilson, C. B.; Dixon, F. J.; Starzl, T. E. Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of cìimìQ. Surgery: 1971; 70:103.
Makowka, L.; Miller, C.; Chapchap, P.; Podestà, L.; Pan, C.; Pressley, D.; Mazzaferro, V.; Esquivel, C. O.; Todo, S.; Banner, B.; Jaffe, R.; Saunders, R.; Starzl, T. E. Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann. Surg.: 1987; 206:482.
Merkel, F. K.; Bier, M.; Beavers, C. D.; Merriman, W. G.; Wilson, C.; Starzl, T. E. Modification of xenograft response by selective plasmapheresis. Transplant Proc.: 1971;3:534.
Clark, D. S.; Gewürz, H.; Good, R. A.; Varco, R. L. Complement fixation during homo- graft rejection. Surg. Forum 1964; 15:144.
Clark, D. S.; Foker, J. E.; Pickering, R.; Good, R. A.; Varco, R. L. Evidence for two platelet populations in xenograft rejection. Surg. Forum: 1966; 17:264.
Gerwurz, H.; Clark, D. S.; Finstad, J.; Kelley, W. D.; Varco, R. L.; Good, R. A.; Gabrielson, A. E. Role of C in graft rejection in experimental animals and man. Ann. N.Y.Acad. 1966; 129: 673.
Kemp, E.; Kemp, G.; Starklint, H.; Larsen, S. Immunosuppression with cobra venom factor, anti-platelet aggregator, and cyclosporin A in renal xenotransplantation. Transplant Proc.: 1982; 14:116.
Kemp, E.; Kemp, G.; Svendsen, P.; Nielsen, E.; Buhl, M. R. Prolongation of xenograft survival by infusion of heterologous antibodies against recipient serum. Acta Pathol. Microbiol. Scand: 1976; 84C: 342.
Kemp, E.; Kemp, G.; Abildgaard-Jacobsen, I.; Lundborg, C. Prolongation of survival of renal xenografts by infusion of donor blood. Acta Pathol. Microbiol. Scand. (A); 1977; 85(A): 267.
Kemp, E.; Steinbruchel, D.; StarkHnt, H.; Larsen, S.; Henriksen, L; Dieperink, H. Renal xenograft rejection: Prolonging effect of Captopril, ACE-inhibitors, prostacyclin, and cobra venom factor. Transplant Proc.: 1987; 19:4471.
Kemp, E.; White, D.; Dieperink, H.; Larsen, S.; Starklint, H.; Steinbruchel, D. Delayed rejection of rabbit kidneys transplanted into baby pigs. Transplant Proc.: 1987; 19:1143.
Reding, R.; Davies, H. ff. S.; White, D. J. G.; Wright, L. J.; Marbaix, E.; Alexandre, G. P. J.; Squifflet, J. P.; Calne, R. Y. Effect of plasma exchange on guinea pig-to-rat heart xenografts. Transplant Proc.: 1989; 21:534.
Fischel, R. J.; Bolman, R. M. III; Piatt, J. L.; Najarian, J. S.; Bach, F. H.; Matas, A. J. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival. Transplant Proc.: 1990; 22:1077.
Cooper, D. K.C.; Human, P. A.; Rose, A. G.; Rees, J.; Keraan, M.; DuToit, E.; Oriol, R. Can cardiac allografts and xenografts be transplanted across the ABO blood group barrier? Transplant Proc: 1989; 21:549.
Cooper, D. K. C. Xenograft transplantation. Transplantation: 1989; 47:408.
Cooper, D. K. C.; Human, P. A.; Lexer, G., Rose, A.G., Rees, J., Keraan, M., Du Toit, E.; Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J. Heart Transplant.; 1988; 7:238.
Landsteiner, K. Specificity of Serological Reactions. New York: Dover Publ.; 1962.
Platt, J. L.; Lindman, B. J.; Chen, H.; Spitalnik, S. L.; Bach, F. H. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation; 1990; 50: 817.
Platt, J. L.; Turman, M. A.; Noreen, H. J.; Fischel, R. J.; Bolman, R. M.; Bach, F. H. An Elisa assay for xenoreactive natural antibodies. Transplantation; 1990; 49:1000.
Edwards, N.; Ott, G.; Berger, C.; He, X.; Teppler, I.; Copey, L.; Smith, C.; Reemtsma, K.; Rose, E. Incidence of preformed antibodies against potential xenodonors in human sera. Transplantation; 1990; 49:1022.
Sachs, D. H.; Winn, H. J.; Russell, P. S. The immunologic response to xenografts: recognition of mouse H-2 histocompatibility antigens by the rat. J. Immunol.; 1971; 107:481.
Staines, N. A. Relative immunogenicity of H-2 and other membrane components in xenoimmunization. Transplantation; 1974; 17:470.
Bouwman, E.; de Bruin, R. W. F.; Marquet, R. L.; Jeekel, J. Prolongation of graft survival in sensitized xenotransplantation. Transplant Proc.; 1989; 21:551.
Bouwman, E.; de Bruin, R. W. F.; Marquet, R. L.; Jeekel, J. Prolongation of graft survival in hamster to rat xenografting. Transplant Proc.; 1989; 21:540–1.
Nakajima, K.; Sakamoto, K.; Asano, T.; Isono, K. Effects of 15-deoxysperguahn and FK506 on the histology and survival of hamster-to-rat cardiac xenotransplantation. Transplant Proc.; 1989; 21:546.
Monden, M.; Valdivia, L. A.; Gotoh, M.; Kubota, N.; Hasuike, Y.; Nakano, Y.; Okamura, J.; Mori, T. A crucial effect of splenectomy on prolonging cardiac xenograft survival in combination with cyclosporine. Surgery 1989; 105:535.
Valdivia, L. A.; Monden, M.; Gotoh, M.; Kubota, N.; Hasuike, Y.; Nakano, Y.; Okamura, J.; Mori, T. Prolonged cardiac xenograft survival by 15-deoxyspergualin combined with splenectomy. Transplant Proc.; 1989; 21:532.
Valdivia, L. A.; Monden, M.; Gotoh, M.; Hasuike, Y.; Kubota, N.; Ichikawa, T.; Okamura, J.; Mori, T. Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration. Transplantation; 1987; 44:759.
Valdivia, L.A.; Monden, M.; Gotoh, M.; Nakano, Y.; Tono, T.; Mori, T. Evidence that 15-deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation. Transplantation; 1990; 50:132.
Gordon, R. D.; Fung, J. J.; Markus, B.; Fox, I.; Iwatsuki, S.; Esquivel, C. O.; Tzakis, A.; Todo, S.; Starzl, T. E. The antibody crossmatch in liver transplantation. Surgery; 1986; 100:705.
Gordon, R. D.; Iwatsuki, S.; Esquivel, C. O.; Tzakis, A.; Todo, S.; Starzl, T. E. Liver transplantation across ABO blood groups. Surgery; 1986; 100:342.
Settaf, A.; Meriggi, F.; van de Stadt, J.; Gane, P.; Crougneau, S.; Reynes, M.; Rouger, P.; Houssin, D. Delayed rejection of liver xenografts compared to heart xenografts in rats. Transplant Proc.; 1987; 19:1155.
Starzl, T. E.; Ishikawa, M.; Putnam, C. W.; Porter, K. A.; Picache, R.; Husberg, B. S.; Balgrimson, C. G.; Schröter, G. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc.; 1974; 6:129.
Knechtle, S. J.; Kolbeck, P. C.; Tsuchimoto, S.; Coundouriotis, A.; Sanfilippo, F.; Bollinger, R. R. Hepatic transplantation into sensitized recipients: demonstration of hyperacute rejection. Transplantation 1987; 43:8.
Merion, R. M.; Colletti, L. M. Hyperacute rejection in porcine liver transplantation. I. Clinical characteristics, histopathology, and disappearance of donor-specific lympho- cytotoxic antibody from serum. Transplantation; 1990; 49:861–868.
Baldamus, C. A.; Winn, H. J.; Russell, P. S. Acute rejection of skin xenografts in the mouse after passive transfer of humoral antibody. Fed. Proc.; 1970; 29:785.
Jooste, S. v.; Colvin, R. B.; Winn, H. J. The vascular bed as the primary target in the destruction of skin grafts by antiserum: II. Loss of sensitivity to antiserum in long-term xenografts of skin. J. Exp. Med.; 1981; L54:1332.
Delmonico, F. L.; Chase, C. M.; Russell, P. S. Transplantation of rat islets of Langerhans into diabetic mice. Transplant Proc.: 1977; 9:367.
Naji, A.; Reckard, C. R.; Ziegler, M. M.; Barker, C. F. Vulnerability of pancreatic islets to immune cells and serum. Surg Forum; 1975; 26:459.
Frangipane, L. G.; Poole, T. W.; Barker, C. F.; Silvers, W. K. Vulnerability of allogeneic and xenogeneic islets to alloantisera. Transplant Proc.; 1977; 9:371.
Perloff, L. J.; Naji, A.; Barker, A. F. Islet sensitivity to humoral antibody. Surg. Forum; 1981; 32:390.
Ricordi, C.; Kneteman, N. M.; Scharp, D. W.; Lacy, P. E. Transplantation of cryopreserved human pancreatic islets into diabetic nude mice. World Surg; 1988; 12:861.
Ricordi, C.; Lacy, P. E.; Sterbenz, K.; Davie, J. M. Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc. Natl. Acad. Sci. USA; 1987; 84:8080.
Ricordi, C.; Lacy, P. E. Renal subcapsular xenotransplantation of purified porcine islets. Transplantation; 1987; 44:721.
Ricordi, C.; Scharp, D. W.; Lacy, P. E. Reversal of diabetes in nude mice after transplantation of fresh and 7-day-cullured (24 degrees C) human pancreatic islets. Transplantation; 1988; 45: 994.
Lacy, P. E.; Ricordi, C.; Finke, E. H. Effect of transplantation site and anti alpha L3T4 treatment on survival of rat, hamster, and rabbit islet xenografts in mice. Transplantation; 1989; 47:761.
Sullivan, F. P.; Ricordi, C.; Hauptfeld, V.; Lacy, P. E. Effect of low-temperature culture and site of transplantation on hamster islet xenograft survival (hamster to mouse). Transplantation; 1987; 44:465.
Chabot, J.; Weber, C.; Hardy, M. A.; Rivera, S.; Bailey-Braxton, D.; Strausberg, L.; Wood, M.; Chow, J.; Pi-sunyer, F. X.; Reemtsma, K. Synergy of ALS and UV-B in prolongation of primate-to-mouse islet xenograft survival. Transplant Proc.; 1987; 19:1160.
Auchincloss, H. Jr. Xenogeneic transplantation. A review. Transplantation; 1988; 46:1.
Manning, D. D.; Reed, N. D.; Shaffer, C. F. Maintenance of skin xenografts of widely divergent phylogenetic origin on congenitally athymic (nude) mice. J. Exp. Med.; 1973; 138:488.
Hullett, D. A.; Falany, J. L.; Love, R. B.; Burlingham, W. J.; Pan, M.; Sollinger, H. W. Human fetal pancreas - A potential source for transplantation. Transplantation; 1987; 43:18.
Monaco, A. P.; Wood, M. L.; Gray, J. G.; Russell, P. S. Studies on heterologous anti-lymphocyte serum in mice: Effect on the immune response. J. Immunol; 1966; 96:229.
Monaco, A. P.; Wood, M. L.; Russell, P. S. Studies on heterologous anti-lymphocyte serum in mice: III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum. Ann N. Y. Acad. Sci.; 1966; 129: 190.
Lance, E. M.; Medawar, P. B. Survival of skin heterografts under treatment with anti- lymphocyte serum. Lancet; 1968; 1:1174.
Dieperink, H.; Steinbruchel, D.; Starklint, H.; Larsen, S.; Kemp, E. Improvement in hare-to-rabbit kidney transplant survival. Transplant Proc.; 1987; 19:1140.
Kemp, E.; Starkhnt, H.; Larsen, S.; Dieperink, H. Cyclosporine in concordant renal hare-to-rabbit xenotransplantation: prolongation and modification of rejection, and adverse effects. Transplant Proc.; 1985; 17:1351.
Valdivia, L. A.; Monden, M.; Gotoh, M.; Hasuike, Y.; Kubota, N.; Endoh, W.; Okamura, J.; Mori, J. Hepatic xenografts from hamster to rat. Transplant Proc.; 1987; 19:1158.
Monden, M.; Valdivia, L. A.; Gotoh, M.; Hasuike, Y.; Kubota, N.; Kanai, T.; Okamura, J.; Mori, T. Hamster to rat orthotopic liver transplantation. Transplantation; 1987; 43: 745.
Michler, R. E.; McManus, R. P.; Smith, C. R.; Sadeghi, A. N.; Marboe, C. C.; Reemtsma, K.; Rose, E. A. Prolongation of primate cardiac xenograft survival with cyclosporine. Transplantation; 1987; 44:632.
Calne, R. Y.; White, H. J. O.; Herbertson, B. M.; Millard, P. R.; Davis, D. R.; Salaman, J. R.; Samuel, J. R. Pig to baboon liver xenografts. Lancet; 1968; 1:1176.
Sollinger, H. W.; Burkholder, P. M.; Rasmus, W. R.; Bach, F. H. Prolonged survival of xenografts after organ culture. Surgery; 1977; 81:74.
Steinmuller, D. Cross-species transplantation in embryonic and neonatal animals. TransplantProc.; 1970; 2:438.
Brendel, W.; Duswald, K. H.; von Scheel, J.; Chaussy, C.; Sollinger, H. W.; Hammer, C. Prolonged survival time of canine xenografts using a new schedule of horse anti-dog lymphocyte globulin (ALG) therapy. Transplant Proc.; 1978; 9:379.
Hammer, C.; Chaussey, C.; Welter, H.; Weinbacher, J.; Hobel, G.; Brendel, W. Exceptionally long survival time in xenogeneic organ transplantation. Transplant Proc.; 1981; 13:881.
Hammer, C.; Chaussy, C.; von Scheel, J.; Pongratz, H.; Roscher, E.; Pielsticker, K. Survival times of skin and kidney grafts within different canine species in relation to their genetic markers. Transplant Proc.; 1975; 7:439.
Chaussy, C.; Hammer, C.; Pongratz, H.; von Scheel, J.; Pfeifer, K. J.; Land, W.; Sollinger, H. W.; Pielsticker, K. Prolongation of graft survival in rats and dogs by a specific antimacrophage serum (AMS). Transplant Proc.; 1975; 7:779.
Chaussy, C.; Hammer, C.; von Scheel, J.; Pielsticker, K.; Sollinger, H. W.; Pfeifer, K. J.; Pongratz, H. Xenogeneic skin and kidney transplants in a closely related canine system, fox-dog. Transplantation; 1975; 20:150.
Perper, R. J. Renal heterotransplant rejection: a model for separation of humoral and cellular mechanisms. Transplantation; 1971; 12:519.
Perper, R. J.; Monovich, R. E.; Bowersox, B. E. Long-term skin allograft survival elicited by a finite treatment with anti-lymphocyte serum combined with cytarabine. J. Immunol; 1970; 104:1063.
Burdick, J. F.; Jooste, S. V.; Winn, H. J. Variations in the responses of mouse strains to rat xenografts. J. Immunol; 1979; 123:954.
Jooste, S. V.; Winn, H. J. Strain variation in the responses of mice to xenografts of skin. TransplantProc; 1977; 9:375.
Pierson, R. N, III; Winn, H. J.; Russell, P. S.; Auchincloss, H. Jr. Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J. Exp. Med.; 1989; 170:991.
Thomas, F. T.; De Masi, R.; Daniel, H.; et al. Comparative immunosuppression for xenografting. In: Hardy, M. A., (ed). Xenograft 25. The Netherlands: Elsevier, Amsterdam, New York, Oxford, 1989, p. 55.
Bailey, L. L.; Nehlsen-Cannarella, S. L.; Concepcion, W.; Jolley, W. B. Baboon-to-human cardiac xenotransplantation in a neonate. J.A.M.A.; 1985; 254:3321.
Sakakibara, N.; Click, R. E.; Condie, R. M.; Jamieson, S. W. Rejection acceptance of xenografts. Transplant proc.; 1989;21:524.
Dennert, G. Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens. J. Immunol; 1974; 113:201.
Moller, G.; Svehag, S. E. Specificity of lymphocyte-mediated cytotoxicity induced by in vitro antibody coated target cells. Cell Immunol; 1972; 4:1.
Harding, B.; MacLennan, I. C. M. The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells. Immunology, 1972; 23:35.
Escobar, M. R.; Sigel, M. M. Effects of lymphoid cells and serum on target cells in xenogeneic cell-culture systems. Proc. Soc. Exp. Biol Med.; 1970; 134:744.
Grant, C. K.; Avis, P. J.; Hale, J. G.; Alexander, P. Evidence for the role of antibody in the cytotoxic action of lymph cells on xenogeneic target cells. Transplantation; 1971; 11: 356.
Shons, A. R.; Kromrey, C.; Najarian, J. S. Xenogeneic mixed lymphocyte response. Cell 1973:6:420.
Woolnough, J. A.; Misko, I. S.; Laffcrty, K. J. Cytotoxic and proliferative response to allogeneic and xenogeneic antigens in vitro. Aiist. J. Exp. Biol. Med. Sci.: 1979; 57:467.
Wilson D. B.; Fox, D. H. Quantitative studies on the mixed lymphocyte interaction in rats: VI. Reactivity of lymphocytes from conventional and germfrcc rats to allogeneic and xenogeneic cell surface antigens. 7. J. Exp. Med. : 1971; 134:857.
Wilson, D. B.; Nowell, P. C. Quantitative studies on the mixed lymphocyte interaction in rats: IV. Immunological potentiality of the responding cells. J. Exp. Med. 1970; 131: 39.
Yoshizawa, K.; Yano, A. Mouse T lymphocytes proliferative responses for human MHC products in mouse anti-human xenogeneic MLR. J. Immunol.; 1984; 132: 2820.
Swain, S. L.; Dutton, R. W.; Schwab, R.; Yamamoto, J. Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T celLsubsets responsible for allospecific and major histocompatibilitv complex-restricted responses. J. Exp. Med.; 1983; 157:720.
Peck, A. B.; Alter, B. J.; Lindahl, K. F. Specificity in T cell mediated lympholysis: identical genetic control of the proliferative and effector phases of allogeneic and xenogeneic reactions. Transplant Rev.: 1976; 29:189.
Lindahl, K. F.; Bach, F. H. Genetic and cellular aspects of xenogeneic mixed lymphocyte culture reaction. J. Exp. Med.:1916: 144:305.
Hirshberg, H.; Rankin, B.; Thorsby, E. Specificity of human lymphocytes proliferating in response to allogeneic and xenogeneic cells in vitro. Transplantation 1974; 17:593.
Bach, F. H.; Engstrom, M. A.; Bach, M. L.; Sell, K. W. Histocompatibility matching: VII Mixed leukocyte cultures between chimpanzee and man. Transplant Proc.: 1972; 4: 97.
Nielsen, H. E. Reactivity of lymphocytes from germfree rats in mixed leukocyte culture and in graft-versus-host reaction. J. Exp. Med.; 1972; 136:417.
Widmer, M. B.; Bach, F. H. Allogeneic and xenogeneic response in mixed leukocyte cultures. J. Exp. Med.: 1972; 135:1204.
Widmer, M. B.; Sondel, P. M.; Bach, F. H. Responsiveness of germfree mice in mixed leukocyte culture: Re-examining the nature of the responding unit. J. Exp. Med.; 1972; 136:398.
Harris, J. E.; Hersh, E. M.; Huggins, S. Human immune response to a xenogeneic nucleated cell. Transplantation; 1970; 9:440.
Knight, S. C.; Thorbecke, G. J. Ontogeny of cellular immunity: Development in rat thymocytes of mixed lymphocyte reactivity to allogeneic and xenogeneic cells. Cell Immunol; 1971; 2: 91.
Alter, B.; Bach, F.H. Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J. Exp. Med.; 1990; 171:333.
Lucas, P. J.; Shearer, G. M.; Neudorf, S.; Gress, R. E. The human anti-murine xenogeneic cytotoxic response: I. Dependence on responder antigen presenting cells. J. Immunol; 1990;144 4548
Auchincloss, H. Jr. Xenografting: a review. Transplant Rev.; 1990; 4:1.
Auchincloss, H. Jr.; Pierson, R. N. III.; Russell, P. S.; Winn, H. J. The cell-mediated response to xenogeneic antigens is similar to that to minor allogeneic histocompatibility antigens. Xenograft 25. Hardy, M. A., (ed.) Elsevier, Amsterdam, New York, Oxford, 1989:207.
Moses, R. D.; Pierson, R. N. III; Winn, H. J.; Auchincloss, H. Jr. Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self anti- gen-presenting cells in the mouse. J. Exp. Med.; 1990; 172:567.
Fischer-Lindahl, K.; Wilson, D. B. Histocompatibihty antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J. Exp. Med.; 1977; 145:508.
Hammerling, G. J.; Hunt, T.; Dill, O.; Moreno, J. Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice. Eur.J. Immunol; 1989; 19:599.
Barra, C.; Perarnau, B.; Gerlinger, P.; Lemeur, M; Gillet, A.; Gibier, P.; LeMonnier, F. A. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7xhuman Beta-2 Microglobulin double transgenic mice. J. Immunol; 1989; 143:3117.
Le, A. X.; Bernhard, E. J.; Holterman, M. J.; Strub, S.; Parham, P.; Lacy, E.; Engelhard, V. H. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J. Immunol; 1989; 142: 1366.
Kievits, F; Wijffels, J.; Lokhorst, W.; Ivanyi, P. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted; a study with transgenic mice. Proc. Natl Acad. Sci. USA; 1989; 86:617.
Holterman, M. J.; Engelhard, V. H. HLA antigens expressed on murine cells are preferentially recognized by murine cytotoxic T cells in the context of the H-2 major histocompatibility complex. Proc. Natl Acad. Sci. USA; 1986; 83:9699.
Engelhard, V. H.; Le, A. T.; Holterman, M. J. Species-specific structural differences in the alphal and alpha2 domains determine the frequency of murine cytotoxic T cell precursors stimulated by human and murine class I molecules. J. Immunol; 1988; 141: 1835.
Samberg, N. L.; Scarlett, E. C.; Stauss, H. J. The alpha3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulation. Eur. J. Immunol; 1989; 19:2349.
Irwin, M. J.; Heath, W. R.; Sherman, L. A. Species-restricted interactions between CD8 and the alpha3 domain of class I influence the magnitude of the xenogeneic response. J. Exp. Med.; 1989; 170:1091.
Auchincloss, H. Jr.; Moses, R. D.; Conti, D.; Sundt, T.; Smith, C; Sachs, D. H.; Winn, H. J. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent. Transplant Proc.; 1990; 22:1059.
Maziarz, R. T.; Burakoff, S. J.; Bluestone, J. A. The alpha-3 domain of class I MHC proteins influences cytotoxic T lymphocyte recognition of antigenic determinants located within the alpha-1 and alpha-2 domains. J. Immunol; 1988; 140:4372.
Kalinke, U.; Arnold, B.; Hammerling, G. J. Strong xenogeneic HLA response in transgenic mice after introducing an alpha-3 domain into HLA B27. Nature; 1990; 348:642.
Bernabeu, C.; Maziarz, R.; Spits, H.; de Vries, J.; Burakoff, S. J.; Terhorst, C. Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human B2-mi- croglobulin gene in L cells. J. Immunol; 1984; 133:3188.
Altmann, D. M.; Hogg, N.; Towsdale, J.; Wilkinson, D. Cotransfection of Icam-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nfliwre; 1989; 338:512.
Brunswick, M.; Lake, P. Functional interactions of human and murine lymphoid cells. I. Analysis of primary and secondary responses. Cell Immunol; 1986; 103:441.
Gustafsson, K.; Germana, S.; Hirsch, F.; Pratt, K.; LeGuern, C.; Sachs, D. H. Structure of miniature swine class II DRB genes: Conservation of hypervariable amino acid residues between distantly related mammalian species. Proc. Natl Acad. Sci.USA.; 1990; 87:9798.
Ildstad, S. T.; Russell, P. S.; Chase, C. M.; Sachs, D. H. Long-term survival of primarily vascularized cardiac xenografts in mice repopulated with syngeneic plus xenogeneic bone marrow. Transplant Proc.; 1985; 17:535.
Ildstad, S. T.; Sachs, D. H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature; 1984; 307: 168.
Ildstad, S. T.; Wren, S. M.; Sharrow, S. O.; Stephany, D.; Sachs, D. H. In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneical- ly reconstituted mice (BIO + F344 rat to BIO). J. Exp. Med.; 1984; 160:1820.
Muller-Rucholtz, W.; Muller-Hermelink, H. K.; Wotage, H. U. Induction of lasting hematopoietic chimerism in a xenogeneic (rat to mouse) model. Transplant Proc.; 1979; 11:517.
Trentin, J. J.; Rauchwerger, J. M.; Ballagher, M. T. Genetic resistance to marrow transplantation. Biomed: 1973; 18:109.
van Bekkum, D. W. A new heterologous radiation chimera. Nature; 1964; 202:1311.
van Bekkum, D. W. Radiation chimeras. Transplant Proc.; 1970; 2:479.
van Bekkum, D. W.; Vos, O. Immunologic aspects of homo- and heterologous bone marrow transplantation in irradiated animals. J. Cell Comp. Physiol.; 1957; 50 (Supp 1): 139.
Gengozian, N. Transplantation of rat bone marrow in irradiated mice: Effect of exposure rate. Science; 1964; 146:663.
Gengozian, N.; Carlson, D. E.; Allen, E. M. Transplantation of allogeneic and xenogeneic (rat) marrow in irradiated mice as affected by radiation exposure ratio. Transplantation; 1969; 7: 259.
Gengozian, N.; Makinodan, T. Antibody response of lethally x-irradiated mice treated with rat bone marrow. J. Immunol.; 1956; 77:430.
Zoalberg, O. B.; Vos, O.; van Bekkum, D. W. Surviving rat skin grafts in mice. Nature; 1957; 180:238.
Makinodan, T. Circulating rat cells in lethally irradiated mice protected with rat bone marrow. Proc. Soc. Exp. Biol. Med.; 1956; 92:174.
Gengozian, N.; Makinodan, T.; Congdon, C. C.; Owen, R. E. The immune status of long-term survivors of lethally x-irradiated mice protected with isologous, homologous, or heterologous bone marrow. Proc. Natl. Acad. Sci. USA.; 1958; 44: 560.
Buchsbaum, H. J.; Aliminosa, K. V.; Southam, C. M. Prolonged survival of human skin grafts in immunologically tolerant rats. Transplantation; 1969; 8: 901.
Cerilli, G. J.; Gideon, L. Successful long term inhibition of xenograft rejection. Surg. Forum; 1969; 20:284.
Reilly, R. W.; Woodruff, M. F. A. Induction of tolerance of rat skin in newborn mice. Transplant Bull.; 1961; 28:39.
Hasek, M.; Hort, J. Studies of tolerance after inter-species embryonic parabiosis. In: Mechanisms of Immunological Tolerance. Czech. Acad. Sci.; 1962:143.
Hasek, M.; Hraba, T.; Hort, J. Acquired immunological tolerance of heterografts. Nature 1959;183.1199.
Mitchison, N. A. The results of transplantation of turkey spleen and blood cells into chicken embryos. Transplant Bull.; 1958; 5:66.
Egdahl, R. H.; Good, R. A.; Vareo, R. L. Studies in homograft and heterograft survival. Surgery; 1951;42: 228.
Egdahl, R. H.; Roller, F. R.; Swanson, R. L.; Vareo, R. L. Acquired tolerance to homo- grafts and heterografts in the rat. Ann. N. Y. Acad. Sci; 1958; 73:842.
McKenzie, I. F. C.; Stocker, J.; Ting, A.; Morris, P. J. Human lymphocytotoxic and hemagglutinating activity against sheep and pig cells. Lancet; 1968; 2:386.
Simonsen, M. Artificial production of immunological tolerance. Induced tolerance to heterologous cells and induced susceptibility to virus. Nature; 1955; 175:763.
McCune, J.M.; Namikawa, R.; Kaneshima, H.; Shultz, L.D.; Lieberman, M.; Weissman, I.L. The Scid-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science; 1988; 241:1632.
Mosier, D.E.; Gulizia, R.J.; Baird, S.M.; Wilson, D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature; 1988; 335: 256.
Hume, D. M.; Gayle, W. E. Jr.; Wilhams, G. M. Cross circulation of patients in hepatic coma with baboon partners having human blood. Surg. Gynec. Obstet; 1969; 128:495.
Ham, J. M.; Piróla, R. C.; Davidson, G. M.; Yarrow, S.; Elmsliz, R. G. Pig liver perfusion for the treatment of acute hepatic coma. Surg. Gynec. Obstet.; 1968; 127:453.
Abouna, G. M.; Fisher, L. M.; Still, W. J.; Hume, D. M. Acute hepatic coma successfully treated by extracorporeal baboon liver perfusion. Br. Med. J.; 1972; 1:23.
Abouna, G. M.; Ashcroft, T.; Mückle, T. J.; Skillen, A. W.; Hule, C. J.; Kirkley, J. R.; Hodson, A. W. Heterologous extracorporeal hepatic support: hemodynamic, biochemical and immunological observation. Br. J. Surg.; 1970; 57:213.
Saunders, S. J.; Bosnian, S. C. W.; Walls, R.; Terblanche, J.; Harrison, G. C.; Hickman, R.; Biebuyck, J.; Dent, D.; Pearce, S.; Barnard, C. N. Acute hepatic coma treated by cross-circulation with a baboon and by repeated exchange transfusions. Lancet; 1968; 2: 585.
Eiseman, B.; Liem, D. S.; Raffucci, F. Heterologous liver perfusion in treatment of hepatic failure, Surg.: 1965; 162:329.
Norman, J. C.; Saravis, C. A.; Brown, M. E.; McDermott, W. V. Jr. Immunochemical observations in clinical heterologous (xenogeneic) liver perfusions. Surgery; 1966; 60: 179.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Auchincloss, H. (1991). The Scientific Study of Xenografting: 1964–1988. In: Cooper, D.K.C., Kemp, E., Reemtsma, K., White, D.J.G. (eds) Xenotransplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97323-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-97323-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97325-3
Online ISBN: 978-3-642-97323-9
eBook Packages: Springer Book Archive